Venture Capital Investors

Domain Associates

Domain Associates is a VC investing group that helps tech companies with financing and expertise.

Venture Investor Overview

Venture Investor
Domain Associates
Status
InActive
Investor Type
Venture Capital
Activity Level
300 transactions
Funds Raised
At least $1.2 billion
Industry Focus
Biopharmaceutical

Contact Information

Contact
James Blair
Title
Co-Founder & Partner
Mailing Address
12481 High Bluff Dr. 150
San Diego, CA 92130
USA
Phone
(858) 480-2400
Website
www.domainvc.com
Email Address
Not Recorded

Background Information

Overview
Founded in 1985, Domain Associates is a venture capital firm with an exclusive focus on life sciences. Domain's three major investment segments are pharmaceuticals, specialty pharmaceuticals, and Medical Devices & Instruments, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics.
Profile
Domain Associates LinkedIn Company Profile
Social Media
Domain Associates Company Twitter Account
Company News
Domain Associates News
Facebook
Domain Associates on Facebook
YouTube
Domain Associates on YouTube
Last Transaction
4/14/2023

Transaction History

Our records indicate that Domain Associates invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Epic Sciences
4/14/2023
$24,000,000
Antios Therapeutics
11/6/2021
$75,000,000
Seraphina Therapeutics
10/16/2021
$5,000,000
Axial Biotherapeutics
10/14/2021
$37,250,000
Antios Therapeutics
4/13/2021
$96,000,000
Fractyl Laboratories
8/7/2020
$55,000,000
Seraphina Therapeutics
5/21/2020
$5,500,000
Aspen Neuroscience
4/2/2020
$70,000,000
Omniome
1/10/2020
$60,000,000
ChromaCode
12/18/2019
$28,000,000
Aspen Neuroscience
12/13/2019
$6,500,000
Truvian Sciences
11/26/2019
$27,100,000
Sera Prognostics
11/14/2019
$36,000,000
Axial Biotherapeutics
2/28/2019
$25,000,000
Antios Therapeutics
11/28/2018
$25,000,000
Milestone Pharmaceuticals
10/26/2018
$80,000,000
Omniome
7/31/2018
$60,000,000
Fractyl Laboratories
12/1/2017
$44,000,000
Milestone Pharmaceuticals
7/26/2017
$55,000,000
Sebacia
7/26/2017
$36,000,000
Iterum Therapeutics
5/20/2017
$65,000,000
Epic Sciences
4/28/2017
$40,000,000
ChromaCode
4/27/2017
$12,024,997
Adynxx
1/11/2017
$16,000,000
Axial Biotherapeutics
12/1/2016
$19,000,000
Revision Optics
11/11/2016
$32,000,000
Rox Medical
9/7/2016
$40,000,000
Obalon Therapeutics
3/31/2016
$15,843,000
Sebacia
3/31/2016
$2,000,000
Omniome
3/31/2016
$8,400,000
Celtaxsys
3/31/2016
$17,034,000
Fractyl Laboratories
11/19/2015
$57,000,000
Sera Prognostics
9/30/2015
$3,439,000
Syndax Pharmaceuticals
8/24/2015
$80,000,000
Xagenic
7/10/2015
$11,780,000
Sebacia
6/25/2015
$22,000,000
Milestone Pharmaceuticals
6/16/2015
$17,000,000
Celtaxsys
6/9/2015
$40,000,000
Benvenue Medical
3/31/2015
$13,875,000
Obalon Therapeutics
1/14/2015
$30,000,000
CoLucid Pharmaceuticals
1/13/2015
$37,100,000
Cantex Pharmaceuticals
12/31/2014
$13,502,000
NovaDigm Therapeutics
12/31/2014
$7,000,000
Sequent Medical
12/31/2014
$100,000
Afferent Pharmaceuticals
9/30/2014
$2,700,000
Epic Sciences
7/30/2014
$30,000,000
TWELVE
6/30/2014
$9,076,000
Benvenue Medical
6/19/2014
$64,000,000
Otonomy
4/30/2014
$49,000,000
Sequent Medical
4/4/2014
$20,000,000
Miramar Labs
2/13/2014
$10,000,000
Neothetics
2/12/2014
$8,000,000
Atara Biotherapeutics
1/10/2014
$13,500,000
Santa Maria Biotherapeutics
12/31/2013
$17,999,000
Achaogen
12/31/2013
$10,000,000
Atara Biotherapeutics
12/18/2013
$38,500,000
Xagenic
12/2/2013
$20,000,000
RightCare Solutions
11/13/2013
$5,000,000
Rox Medical
9/30/2013
$2,614,000
Afferent Pharmaceuticals
9/30/2013
$3,000,000
Nexenta Systems
9/30/2013
$2,000,000
Tragara Pharmaceuticals
9/30/2013
$12,000,000
Otonomy
9/4/2013
Unknown
Syndax Pharmaceuticals
8/27/2013
$26,600,000
Applied Proteomics
8/20/2013
$28,000,000
Dicerna Pharmaceuticals
8/1/2013
$60,000,000
Revision Optics
7/30/2013
$55,000,000
aTyr Pharma
7/29/2013
$49,000,000
Calderome
6/30/2013
$14,950,200
IntegenX
6/30/2013
$10,000,000
Benvenue Medical
6/30/2013
$10,000,000
Veracyte
6/28/2013
$28,000,000
Esperion Therapeutics
4/25/2013
$33,000,000
Revision Optics
4/17/2013
$14,999,998
Nina Biotherapeutics
3/31/2013
$1,005,000
Pinta Biotherapeutics
3/31/2013
$4,294,000
Regado Biosciences
3/31/2013
$10,311,000
Afferent Pharmaceuticals
3/31/2013
$5,000,000
Marinus Pharmaceuticals
3/31/2013
$9,564,000
Glaukos
2/8/2013
$30,000,000
IntegenX
12/31/2012
$9,400,000
Tandem Diabetes Care
12/31/2012
$20,000,000
Adynxx
12/31/2012
$2,000,000
Afferent Pharmaceuticals
12/31/2012
$5,000,000
Aldexa Therapeutics
12/31/2012
$4,794,000
Regado Biosciences
12/20/2012
$51,000,000
Neothetics
12/20/2012
$20,600,000
Marinus Pharmaceuticals
12/18/2012
$21,000,000
Kona Medical
12/4/2012
$10,000,000
Epic Sciences
11/13/2012
$13,000,000
RightCare Solutions
10/11/2012
$1,750,000
IntegenX
9/30/2012
$14,440,000
Foundry Newco XII
6/30/2012
$15,000,100
Adynxx
6/30/2012
$2,000,000
Benvenue Medical
6/29/2012
$25,000,000
Astute Medical
6/7/2012
$40,400,000
Kona Medical
5/30/2012
$30,000,000
Zyga Technology
5/17/2012
$25,000,000
Afferent Pharmaceuticals
3/31/2012
$5,000,000
Kalidex Pharmaceuticals
3/31/2012
$6,499,900
Applied Proteomics
3/31/2012
$22,500,000
VentiRx Pharmaceuticals
3/31/2012
$6,250,100
Durata Therapeutics
3/31/2012
$22,000,000
Sequent Medical
3/7/2012
$26,000,000
Carticept Medical
1/18/2012
$10,000,000
Aria Diagnostics
1/10/2012
$52,700,000
Meritage Pharma
12/31/2011
$1,000,000
Regado Biosciences
12/31/2011
$3,550,000
Afferent Pharmaceuticals
12/31/2011
$2,000,000
Celator Pharmaceuticals
12/31/2011
$2,577,000
NovaDigm Therapeutics
12/31/2011
$4,000,000
IntegenX
12/13/2011
$40,000,000
Sera Prognostics
11/15/2011
$19,300,000
Veracyte
9/30/2011
$9,312,000
Apnex Medical
9/30/2011
$20,000,000
Adynxx
9/30/2011
$2,000,000
Astute Medical
9/30/2011
$6,000,000
Durata Therapeutics
9/30/2011
$22,000,000
Zyga Technology
6/30/2011
$5,000,000
Kona Medical
6/30/2011
$2,903,000
Celator Pharmaceuticals
6/30/2011
$5,000,000
Otonomy
6/30/2011
$14,177,900
Afferent Pharmaceuticals
6/30/2011
$2,000,000
Meritage Pharma
6/30/2011
$3,500,000
Sebacia
6/30/2011
$5,600,000
Benvenue Medical
4/18/2011
$35,500,000
CoDa Therapeutics
4/18/2011
$19,200,000
Oraya Therapeutics
4/5/2011
$15,875,000
BioNano Genomics
3/17/2011
$23,300,000
Astute Medical
3/8/2011
$13,000,000
IntegenX
2/4/2011
$15,600,000
Tobira Therapeutics
12/31/2010
$1,500,000
Oraya Therapeutics
12/31/2010
$5,000,000
aTyr Pharma
10/26/2010
$23,000,000
Carticept Medical
9/30/2010
$10,000,000
Tobira Therapeutics
9/30/2010
$31,000,000
ParinGenix
9/30/2010
$5,000,000
Neothetics
9/30/2010
$3,000,000
Celator Pharmaceuticals
9/1/2010
$20,000,000
Otonomy
8/30/2010
$38,500,000
Dicerna Pharmaceuticals
8/11/2010
$25,000,000
Zogenix
7/14/2010
$50,000,000
Aldexa Therapeutics
6/30/2010
$3,039,400
Tandem Technologies
6/30/2010
$12,500,000
Tandem Diabetes Care
6/30/2010
$5,500,000
Sonexa Therapeutics
6/30/2010
$37,233,000
Afferent Pharmaceuticals
6/30/2010
$2,826,400
Corridor Pharmaceuticals
6/30/2010
$14,475,000
Evoke Pharma
6/30/2010
$6,000,000
Veracyte
6/10/2010
$28,000,000
Sequent Medical
5/13/2010
$15,600,000
Astute Medical
5/11/2010
$26,500,000
Achaogen
4/7/2010
$56,000,000
CoLucid Pharmaceuticals
3/31/2010
$13,800,000
Nuon Therapeutics
3/17/2010
$6,050,000
Carticept Medical
3/9/2010
$20,000,000
Tragara Pharmaceuticals
2/8/2010
$5,000,000
Syndax Pharmaceuticals
2/3/2010
$9,000,000
VentiRx Pharmaceuticals
1/12/2010
$25,000,000
NovaDigm Therapeutics
12/31/2009
$6,586,000
Clovis Oncology
12/31/2009
$65,635,000
Regado Biosciences
12/17/2009
$40,000,000
Afferent Pharmaceuticals
12/16/2009
$23,000,000
Apnex Medical
12/3/2009
$14,000,000
Celion Networks
11/16/2009
$15,000,000
IntegenX
11/12/2009
$18,100,000
Altair Therapeutics
11/12/2009
$17,000,000
Cortria
9/30/2009
$1,841,000
Alimera Sciences
9/30/2009
$5,000,000
Meritage Pharma
9/30/2009
$3,428,000
CoLucid Pharmaceuticals
9/30/2009
$1,500,000
Zogenix
9/23/2009
$51,000,000
SkinMedica
6/30/2009
$4,924,000
Clovis Oncology
6/30/2009
$146,300,000
Neothetics
6/30/2009
$10,000,000
IntegenX
6/30/2009
$3,000,000
Celion Networks
4/10/2009
$10,000,000
Marinus Pharmaceuticals
4/10/2009
$20,000,000
Optherion
3/31/2009
$5,000,000
Sonexa Therapeutics
3/31/2009
$13,525,000
CoLucid Pharmaceuticals
3/31/2009
$1,500,000
GI Dynamics
2/9/2009
$15,000,000
Meritage Pharma
12/31/2008
$11,286,000
Altea Therapeutics
12/31/2008
$1,842,000
Cortria
12/31/2008
$1,699,900
Corthera
12/31/2008
Unknown
Calixa Therapeutics
12/31/2008
$15,125,000
CoDa Therapeutics
9/30/2008
$8,000,000
Syndax Pharmaceuticals
9/30/2008
$19,600,000
Tobira Therapeutics
9/30/2008
$30,000,000
NeuroPace
9/30/2008
$23,142,000
Aesthetic Sciences
9/30/2008
$3,000,000
Oceana Therapeutics
9/29/2008
Unknown
Aldexa Therapeutics
8/8/2008
$8,960,000
NovaDigm Therapeutics
7/30/2008
$4,000,000
Celator Pharmaceuticals
7/29/2008
$22,500,000
CoLucid Pharmaceuticals
7/1/2008
$25,000,000
HDL Therapeutics
6/30/2008
$10,250,000
Corthera
6/30/2008
$11,517,000
Tier One Pharma
6/30/2008
$3,000,000
Five Prime Therapeutics
6/30/2008
$40,282,000
VentiRx Pharmaceuticals
6/30/2008
$13,301,000
Optherion
6/30/2008
$15,000,000
Immune Control
6/30/2008
$6,004,000
BiPar Sciences
6/30/2008
$17,500,000
Tandem Diabetes Care
6/26/2008
$13,050,000
Meritage Pharma
6/16/2008
$22,500,000
Rox Medical
6/2/2008
$35,000,000
Esperion Therapeutics
5/1/2008
$22,750,000
Nuon Therapeutics
4/28/2008
$27,000,000
TargetRx
4/7/2008
$9,600,000
Neothetics
3/31/2008
$10,000,000
ParinGenix
3/31/2008
$12,700,000
Ascenta Therapeutics
3/31/2008
$20,000,000
Alimera Sciences
3/18/2008
$30,000,000
Miramar Labs
3/15/2008
$20,340,000
Obalon Therapeutics
2/27/2008
$4,700,000
Ocera Therapeutics
2/20/2008
$35,500,000
BioVascular
2/7/2008
$10,870,000
Sonexa Therapeutics
1/31/2008
$30,000,000
Zogenix
1/9/2008
$18,000,000
DiObex
12/31/2007
$5,000,000
REVA Medical
12/10/2007
$42,000,000
Calixa Therapeutics
12/4/2007
Unknown
Corthera
11/2/2007
$20,000,000
Novalar Pharmaceuticals
11/1/2007
Unknown
Optherion
10/9/2007
$37,000,000
CoDa Therapeutics
9/30/2007
$2,600,000
Immune Control
9/30/2007
$2,800,000
Sequel Pharmaceuticals
9/27/2007
$20,000,000
Helixis
8/30/2007
$10,000,000
Celator Pharmaceuticals
8/2/2007
$10,000,000
Tobira Therapeutics
8/1/2007
$31,000,000
Ruxton Pharmaceuticals
6/30/2007
$3,570,000
Altea Therapeutics
6/30/2007
$4,722,000
Pharmena North America
6/30/2007
$3,100,000
CoLucid Pharmaceuticals
6/30/2007
$8,250,000
Cardio Polymers
6/30/2007
$5,001,000
Evolenci
6/22/2007
$3,290,000
Apnex Medical
5/14/2007
$16,100,000
Revision Optics
4/30/2007
$25,000,000
DiObex
4/16/2007
$24,000,000
Ascenta Therapeutics
4/9/2007
$50,000,000
Syndax Pharmaceuticals
4/3/2007
$40,000,000
Neothetics
3/31/2007
$1,500,000
NovaCardia
3/31/2007
$18,000,200
Regado Biosciences
3/27/2007
$23,000,000
Orqis Medical
3/26/2007
$12,000,000
Carticept Medical
3/20/2007
$20,000,000
Tragara Pharmaceuticals
3/15/2007
$40,000,000
VentiRx Pharmaceuticals
3/6/2007
$28,900,000
BiPar Sciences
2/27/2007
$35,000,000
Cardio Polymers
12/31/2006
$1,972,100
Aesthetic Sciences
11/28/2006
$6,000,000
Alimera Sciences
11/28/2006
$15,900,000
Orexigen Therapeutics
11/22/2006
$30,000,000
CoDa Therapeutics
10/10/2006
$10,000,000
eNeura
9/30/2006
$7,662,000
ParinGenix
9/30/2006
$20,400,000
Celladon
9/30/2006
$11,000,000
NovaCardia
9/29/2006
$48,000,000
Zogenix
8/29/2006
$60,000,000
Cabrellis Pharmaceuticals
8/7/2006
$27,500,000
Esprit Pharma
8/2/2006
$90,000,000
Ocera Therapeutics
7/11/2006
$12,000,000
Verus Pharmaceuticals
6/30/2006
$28,000,000
Acureon Pharmaceuticals
6/30/2006
$2,500,000
SkinMedica
4/11/2006
$11,000,000
Cadence Pharmaceuticals
3/31/2006
$53,800,000
Transcept Pharmaceuticals
1/4/2006
$25,000,000
Alimera Sciences
12/1/2005
$31,800,000
Ascenta Therapeutics
11/5/2005
$30,000,000
Cerexa
8/23/2005
$50,000,000
Regado Biosciences
8/12/2005
$20,000,000
Altea Therapeutics
7/27/2005
$30,000,000
Immune Control
7/14/2005
$11,300,000
Cadence Pharmaceuticals
6/30/2005
$13,800,000
3F Therapeutics
6/30/2005
$6,000,000
Cardio Polymers
6/30/2005
$2,600,000
Orexigen Therapeutics
6/30/2005
$35,000,000
Verus Pharmaceuticals
6/9/2005
$98,000,000
Somaxon Pharmaceuticals
6/6/2005
$65,000,000
Celator Pharmaceuticals
5/3/2005
$40,000,000
Receptor BioLogix
4/28/2005
$33,600,000
SkinMedica
4/6/2005
$15,000,000
Konova
3/31/2005
$2,000,000
Novalar Pharmaceuticals
3/11/2005
$27,000,000
Five Prime Therapeutics
2/8/2005
$45,000,000
GeneOhm Sciences
1/18/2005
$14,000,000
Ascenta Therapeutics
11/5/2004
$5,500,000
Vascular Architects
9/3/2004
$11,600,000
SkinMedica
7/14/2004
$40,000,000
Alimera Sciences
7/9/2004
$26,750,000
Somaxon Pharmaceuticals
6/15/2004
$23,000,000
GI Dynamics
5/24/2004
$12,000,000
Imagine Pharmaceuticals
4/27/2004
$3,700,000
Transcept Pharmaceuticals
1/8/2004
$35,000,000
GeneOhm Sciences
1/21/2003
$12,000,000
Vascular Architects
1/6/2003
$16,000,000
Iomai
1/3/2003
$54,000,000

 

Investor Contacts

Title
Name
Email & Social
Partner
James Blair
  James Blair LinkedIn Profile  James Blair Twitter Account  James Blair News  James Blair on Facebook
Partner
Brian Dovey
  Brian Dovey LinkedIn Profile  Brian Dovey Twitter Account  Brian Dovey News  Brian Dovey on Facebook
Partner
Brian Halak
  Brian Halak LinkedIn Profile  Brian Halak Twitter Account  Brian Halak News  Brian Halak on Facebook
Partner
Kim Kamdar
  Kim Kamdar LinkedIn Profile  Kim Kamdar Twitter Account  Kim Kamdar News  Kim Kamdar on Facebook
Managing Director
Debra Liebert
  Debra Liebert LinkedIn Profile  Debra Liebert Twitter Account  Debra Liebert News  Debra Liebert on Facebook
Partner
Dennis Podlesak
  Dennis Podlesak LinkedIn Profile  Dennis Podlesak Twitter Account  Dennis Podlesak News  Dennis Podlesak on Facebook
Partner
Jesse Treu
  Jesse Treu LinkedIn Profile  Jesse Treu Twitter Account  Jesse Treu News  Jesse Treu on Facebook
Partner
Nicole Vitullo
  Nicole Vitullo LinkedIn Profile  Nicole Vitullo Twitter Account  Nicole Vitullo News  Nicole Vitullo on Facebook
Partner
Eckard Weber
  Eckard Weber LinkedIn Profile  Eckard Weber Twitter Account  Eckard Weber News  Eckard Weber on Facebook

 

Funds

Our database includes the following fund closing(s) for Domain Associates. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Domain Partners IX
12/24/2014
$163,636,363
Domain Partners VIII
8/15/2009
$500,000,000
Domain Partners VI
12/15/2003
$500,000,000

 

Portfolio Companies

Domain Associates has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
3F Therapeutics
Achaogen
Acureon Pharmaceuticals
Adynxx
Aesthetic Sciences
Afferent Pharmaceuticals
Aldexa Therapeutics
Alimera Sciences
Altair Therapeutics
Altea Therapeutics
Antios Therapeutics
Apnex Medical
Applied Proteomics
Aria Diagnostics
Ascenta Therapeutics
Aspen Neuroscience
Astute Medical
Atara Biotherapeutics
aTyr Pharma
Axial Biotherapeutics
Benvenue Medical
BioNano Genomics
BioVascular
BiPar Sciences
Cabrellis Pharmaceuticals
Cadence Pharmaceuticals
Calderome
Calixa Therapeutics
Cantex Pharmaceuticals
Cardio Polymers
Carticept Medical
Celator Pharmaceuticals
Celion Networks
Celladon
Celtaxsys
Cerexa
ChromaCode
Clovis Oncology
CoDa Therapeutics
CoLucid Pharmaceuticals
Corridor Pharmaceuticals
Corthera
Cortria
Dicerna Pharmaceuticals
DiObex
Durata Therapeutics
eNeura
Epic Sciences
Esperion Therapeutics
Esprit Pharma
Evoke Pharma
Evolenci
Five Prime Therapeutics
Foundry Newco XII
Fractyl Laboratories
GeneOhm Sciences
GI Dynamics
Glaukos
HDL Therapeutics
Helixis
Imagine Pharmaceuticals
Immune Control
IntegenX
Iomai
Iterum Therapeutics
Kalidex Pharmaceuticals
Kona Medical
Konova
Marinus Pharmaceuticals
Meritage Pharma
Milestone Pharmaceuticals
Miramar Labs
Neothetics
NeuroPace
Nexenta Systems
Nina Biotherapeutics
NovaCardia
NovaDigm Therapeutics
Novalar Pharmaceuticals
Nuon Therapeutics
Obalon Therapeutics
Oceana Therapeutics
Ocera Therapeutics
Omniome
Optherion
Oraya Therapeutics
Orexigen Therapeutics
Orqis Medical
Otonomy
ParinGenix
Pharmena North America
Pinta Biotherapeutics
Receptor BioLogix
Regado Biosciences
REVA Medical
Revision Optics
RightCare Solutions
Rox Medical
Ruxton Pharmaceuticals
Santa Maria Biotherapeutics
Sebacia
Sequel Pharmaceuticals
Sequent Medical
Sera Prognostics
Seraphina Therapeutics
SkinMedica
Somaxon Pharmaceuticals
Sonexa Therapeutics
Syndax Pharmaceuticals
Tandem Diabetes Care
Tandem Technologies
TargetRx
Tier One Pharma
Tobira Therapeutics
Tragara Pharmaceuticals
Transcept Pharmaceuticals
Truvian Sciences
TWELVE
Vascular Architects
VentiRx Pharmaceuticals
Veracyte
Verus Pharmaceuticals
Xagenic
Zogenix
Zyga Technology

 

 

 

 

Browse more venture capital investors:

Dolphin Equity Partners | Dominance Ventures

 

Share this article

 

About Our VC & M&A Database

This venture capital firm data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.